2-Hydroxybenzothiazole

We are 2-Hydroxybenzothiazole CAS:934-34-9 manufacturer and supplier in China, Pls send inquiry of to info@nbinno.com of visit www.nbinno.com our official website should you have any interests

CAS No: 934-34-9
Product Name: 2-Hydroxybenzothiazole
Other Name:
2-Hydroxybenzothiazole
2(3H)-Benzothiazolone
2-Benzothiazolol
1,3-Benzothiazol-2(3H)-one
Benzo[d]thiazol-2-ol
benzothiazolinone
 
Density: 1.4±0.1 g/cm3
Boiling Point: 360.0±11.0 °C at 760 mmHg
Melting Point: 137-140 °C(lit.)
Molecular Formula: C7H5NOS
Molecular Weight: 151.186
Flash Point: 171.5±19.3 °C
Exact Mass: 151.009186
PSA: 61.36000
LogP: 2.28
Vapour Pressure: 0.0±0.8 mmHg at 25°C
Index of Refraction: 1.745
 
Specification
Appearance: Beige crystal granule
Assay: ≥99.0%
Loss on drying: ≤0.5%
 
Application
Intermediates of Fenthiaprop CAS: 93921-16-5.
Be used as pesticide intermediate, mainly used in the synthesis of the herbicide Fenthiaprop.
 
Package: 25kg/drum, can also be designed according to customer requirements.
Storage: Store in cool place. Keep container tightly closed in a dry and well-ventilated place.

2-Hydroxybenzothiazole


Related News: Immediately thereafter, the iLet begins controlling blood-sugar levels automatically, without requiring the user to count carbohydrates, set insulin delivery rates, or deliver bolus insulin for meals or corrections.1,2,3,4,5-Pentafluorobenzene Immediately thereafter, the iLet begins controlling blood-sugar levels automatically, without requiring the user to count carbohydrates, set insulin delivery rates, or deliver bolus insulin for meals or corrections.(aR,bS)-rel-α-Hydroxy-β-[[(phenylmethoxy)carbonyl]amino]benzenebutanoic acid CAS:76498-22-1 Immediately thereafter, the iLet begins controlling blood-sugar levels automatically, without requiring the user to count carbohydrates, set insulin delivery rates, or deliver bolus insulin for meals or corrections.9-bromo-11,11-dimetilbenzo [a] fluoreno CAS:1198396-29-0 Fate Therapeutics’ iPSC product platform is supported by an intellectual property portfolio of over 250 issued patents and 150 pending patent applications.Fate Therapeutics’ iPSC product platform is supported by an intellectual property portfolio of over 250 issued patents and 150 pending patent applications.

Related Products
Product Name
4-Bromoveratrole View Details
2-Chloromethyl-3,4-dimethoxypyridinium Chloride Cas:72830-09-2 View Details
2-Amino-4-nitrophenol View Details
Lithium chloride Cas:7447-41-8 manufacturer N,N,N’-Trimethyl Ethylenediamine Cas:NO: 142-25-6 manufacturer 1,2,3,9-Tetrahydro-4(H)-Carbazol-4-One manufacturer Atorvastatin Calcium Salt Trihydrate Cas:344423-98-9 manufacturer 3-MERCAPTO-2-PENTANONE Cas:67633-97-0 manufacturer